AT Bancorp »

Alexion Pharmaceuticals shares owned by AT Bancorp

Quarter-by-quarter ownership of Alexion Pharmaceuticals shares owned by AT Bancorp from 13F filings

Historical chart of AT Bancorp investment in Alexion Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alexion Pharmaceuticals held by AT Bancorp consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alexion Pharmaceuticals by AT Bancorp

Quarter filed Position value Share count Share price at filing
2019-03-31 $1.0M 7.7k 135.17
2018-12-31 $746k 7.8k 95.96
2018-09-30 $877k 6.3k 138.95
2018-06-30 $1.1M 8.7k 124.09
2018-03-31 $1.6M 14k 111.48
2017-12-31 $1.6M 14k 119.59
2017-09-30 $679k 4.8k 140.19
2017-06-30 $470k 3.9k 121.68
2017-03-31 $1.0M 8.5k 121.29
2016-09-30 $1.1M 9.0k 122.50

More positions owned by AT Bancorp

Vanguard Short-Term Bond ETF (BSV)
Schwab Strategic Tr us lrg cap etf (SCHX)
Vanguard Europe Pacific ETF (VEA)
Sch Us Mid-cap Etf etf (SCHM)
Vanguard Total Bond Market ETF (BND)
Schwab U S Small Cap ETF (SCHA)
IQ Hedge Multi-Strategy Tracker (QAI)
Vanguard Emerging Markets ETF (VWO)
Ishares Tr Global Reit Etf (REET)
Vanguard FTSE All Wld Ex USSml Cap (VSS)
SPDR Barclays Capital High Yield B
Flexsteel Industries (FLXS)
MidWestOne Financial (MOFG)
Ipath Dow Jones-aig Commodity (DJP)
Heartland Financial USA (HTLF)

View all positions for AT Bancorp

Top funds holding Alexion Pharmaceuticals

Accent Capital Management

View all funds holding Alexion Pharmaceuticals